Skip to content

DR. CEYSENS

Active Private limited companyfounded 2001active for 25 yearsLedeganckkaai 33, 2000 AntwerpKBO/BCE: BE 0474.906.555

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2002
peak of €492,660 in 2026
€492,660▲ 18.8%
peak of €292,783 in 2024
€269,958▲ 24.5%
peak of €1.3m in 2024
€1.0m▲ 2.3%
€1.1m▼ 22.8%
Board2 names since 2001
2 directors and 1 other
Documentsfilings and deeds
13-10-2026110 days before the deadline
2026micro format
Gross margin from €414,786 to €492,660Registered office moved within Antwerp 30-06Dividend €247,366Debts from €1.4m to €1.1mCash from €134,899 to €14,485

Key points

from the 2026 annual accounts

Equity

€1.0m ▲ 2.3%
1.02025+0.3Profit-0.2Dividend1.02026

DR. CEYSENS paid out €247,366 in dividends. That is 92% of the 2026 profit.

Turnover

≈ €990,000 estimated

The micro format states no turnover.

Filings

25 annual accounts since 2002
deadline20102020

The last five annual accounts were filed 21 to 141 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DR. CEYSENS has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DR. CEYSENS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-05-2001
Manager, since 21-05-2001
Board & ownership

Recent changes

Registered office moved within Antwerp The registered office moved from Scheldehof, Jos Smolderenstraat 74 bus 103 te 2000 Antwerpen to Ledeganckkaai 33 bus 701, 2000 Antwerpen · Board meeting of 15-06-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0474906555
Registered office moved to Antwerp The registered office moved to Scheldehof, Jos Smolderenstraat 74 bus 103 te 2000 Antwerpen · appointed as director · “De uitoefening van de geneeskunde door de arts-aandeelhouder of bij uitbreiding door de artsen-aandeelhouders…” (deed in Dutch) · General meeting of 27-11-2023 · Gazette deed
Company renamed to DR.CEYSENS The capital rose from €18,600 to €203,100 · The capital fell from €203,100 to €18,600 · General meeting of 15-01-2019 · Gazette deed
All 41 events

Official details

Source: KBO
Status
Active since 30-05-2001Normal situation
Activity
“De uitoefening van de geneeskunde door de arts-aandeelhouder of bij uitbreiding door de artsen-aandeelhouders.” (deed in Dutch)From the articles, 12 activities2 activities on the establishment unit
Establishment unit
2.370.572.6072000 Antwerp, since 19-01-2003
Financial year end
30 June
Peppol
Reachable since 20-08-2025
Company details

Annual accounts to 30-06-2026

€2.1m▼ 12.5%
Filing
Filed on 13-10-2026, 110 days before the end of the filing period
Financials

Insights on DR. CEYSENS

DR. CEYSENS files the micro format. That format states no turnover. The gross margin rose from €115,117 in 2007 to €492,660 in 2026.

The balance sheet grew most from 2021 to 2023 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. CEYSENS

What is the company number of DR. CEYSENS?
The company number of DR. CEYSENS is 0474.906.555. The VAT number is the same number with BE in front: BE 0474.906.555.
Where is DR. CEYSENS based?
The registered office is at Ledeganckkaai 33, 2000 Antwerp.Company details
What is the legal form of DR. CEYSENS?
DR. CEYSENS is a private limited company (BV).
When was DR. CEYSENS founded?
DR. CEYSENS was founded on 30-05-2001.
Is DR. CEYSENS still active?
Yes, DR. CEYSENS is an active enterprise in the KBO register.
What is the turnover of DR. CEYSENS?
The turnover in financial year 2026 is ≈ €990,000. This figure is estimated from the gross margin of €492,660 and 1,019 comparable companies of the same size. It probably lies between €690,000 and €1.4m. It is a rough estimate.Financials
Is DR. CEYSENS profitable?
In financial year 2026, DR. CEYSENS made a profit of €269,958.
Where can I find the annual accounts of DR. CEYSENS?
DR. CEYSENS filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of DR. CEYSENS due?
DR. CEYSENS must file the annual accounts for financial year 2027 by 31-01-2028.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.